Agile Therapeutics (United States)
- Research works
- 22 ▲ 113% vs 2013–17
- Citations
- 543 25.1 per fractional work
- Top-10% rate
- 8.5% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Agile Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 15.6×. Every wedge is a field page.
- Veterinary 15.6×
- Neuroscience 6.0×
- Pharmacology, Toxicology and Pharmaceutics 6.0×
- Medicine 3.0×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Immunology and Microbiology 1.4×
- Psychology 1.2×
- Agricultural and Biological Sciences 0.9×
- Health Professions 0.5×
- Materials Science 0.4×
- Economics, Econometrics and Finance 0.1×
- Social Sciences 0.0×
- Engineering 0.0×
Which keywords describe research at Agile Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Contraception, Unintended Pregnancy, Inflammation, Adverse Drug Reactions, Cancer, Off-Label Drug Use and Pediatric Pharmacokinetics.
- Off-Label Drug Use
- Epidemiology
- Inflammation
- Contraception
- Clinical Trials
- Unintended Pregnancy
- Cancer
- Adverse Drug Reactions
- Pediatric Pharmacokinetics
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Clinical Trials2▲ 16×5 topics
- Contraception2▲ 399×1 topic
- Unintended Pregnancy2▲ 399×1 topic
- Inflammation2▲ 4.0×10 topics
- Cancer1▲ 4.5×7 topics
- Epidemiology1▲ 1.42×9 topics
- Adverse Drug Reactions1▲ 76×2 topics
- Off-Label Drug Use1▲ 124×1 topic
- Pediatric Pharmacokinetics1▲ 124×1 topic
Which research topics does Agile Therapeutics (United States) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, Neurological disorders and treatments and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 2 Cancer Research and Treatments Biotechnology 0 works
- 3 Neurological disorders and treatments Neurology 0 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 5 Neuroscience of respiration and sleep Endocrine and Autonomic Systems 0 works
- 6 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 7 Cancer Cells and Metastasis Oncology 0 works
- 8 Protein purification and stability Molecular Biology 0 works
- 9 Occupational and environmental lung diseases Pulmonary and Respiratory Medicine 0 works
- 10 Antioxidant Activity and Oxidative Stress Biochemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Agile Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 113% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Princeton
- Princeton University
- Institute for Advanced Study
- Educational Testing Service
- Siemens (United States)
- Textile Research Institute
- Princeton Theological Seminary
- NOAA Geophysical Fluid Dynamics Laboratory
- Mathematica Policy Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.